Skip to main content

Table 3 Reported Mutations in ASAH1 that result in FD

From: Acid ceramidase deficiency: Farber disease and SMA-PME

DNA Change

Mutation type

Locus

Amino acid change

Allelic status

ACDase activity

Number of cases

Reference

c.66G > C

Missense

Exon 1

p.Q22H

NI

NI

1

[195]

c.67C > G

Missense

Exon 1

p.H23D

NI

NI

1

[195]

c.92G > T

Missense

Exon 2

p.C31F

Homoallelic

NI

2

[49, 115]

c.107A > G

Missense

Exon 2

p.Y36C

Homoallelic & Heteroallelic

NI

4

[49, 196]

c.126-3941_382 + 1358del

Deletion

Exon 3–5

p.Y42Rfs*10

Heteroallelic

undetectable

1

[197]

c.174_175InsC

Insertion

Exon 3

p. E64*

Heteroallelic

NI

1

[169]

c.212C > A

Missense

Exon 3

p.P71Q

Heteroallelic

NI

1

[198]

c.256_257insA

Insertion

Exon 4

p.T86Nfs*13

Heteroallelic

NI

1

[17]

c.290_292delTGG

Deletion

Exon 4

p.V96del

Homoallelic

37%

1

[199]

c.290 T > A

Missense

Exon 4

p.V97E

Heteroallelic

35%

1

[199]

c.290 T > G

Missense

Exon 4

p.V97G

Homoallelic

NI

2

[120]

c.314 T > C

Missense

Exon 4

p.L105P

Heteroallelic

NI

1

[17]

c.383-16_383-12delTTTTC

Deletion

Intron 5

–

Heteroallelic

NI

1

[131]

c.372 T > A

Missense

Exon 6

p.D124E

Heteroallelic

NI

1

[198]

c.408 T > A

Missense

Exon 6

p.F136L

Heteroallelic

NI

1

[131]

c.412G > T

Deletion

Exon 6

p.E139*

Heteroallelic

NI

1

[169, 196]

c.410A > G

Missense

Exon 6

p.Y137C

Homoallelic

NI

1

[49]

c.410_411delAT

Deletion

Exon 6

p.Y137*

Heteroallelic

NI

2

[114, 169]

c.413A > T

Missense

Exon 6

p.E138V

Homoallelic & Heteroallelic

< 5%

5

[41, 50, 169, 196]

c.457 + 4A > G

Splicing

Intron 6

–

Homoallelic

NI

2

[121, 131]

c.502G > T

Missense

Exon 7

p.G168W

Homoallelic

undetectable

1

[126]

c.505 T > C

Missense

Exon 8

p.W169R

Homoallelic & Heteroallelic

< 10%

7

[49, 53, 93, 131]

c.538G > A

Missense

Exon 8

p.E180K

Heteroallelic

NI

1

[131]

c.544C > G

Missense

Exon 8

p.L182V

Homoallelic

NI

4

[107, 131]

c.593 T > C

Missense

Exon 8

p.V198A

Heteroallelic

NI

1

[131]

c.626G > A

Missense

Exon 8

p.G209D

Heteroallelic

NI

1

[169]

c.665C > A

Missense

Exon 9

p.T222K

Homoallelic

< 5%

1

[6, 196]

c.677G > C

Missense

Exon 9

p.R226P

Heteroallelic

NI

1

[131]

c.703G > C

Missense

Exon 9

p.G235A

Homoallelic & Heteroallelic

2%

3

[131, 199]

c.704G > A

Missense

Exon 9

p.G235D

Heteroallelic

NI

1

[114]

c.704-2A > G

Splicing

Exon 9

–

Homoallelic

NI

1

[49]

c.760A > G

Missense

Exon 10

p.R254G

Homoallelic & Heteroallelic

< 10%

4

[41, 54, 93, 169, 198]

c.770 T > C

Missense

Exon 10

p.L257P

Homoallelic

NI

1

[55]

c.833C > T

Missense

Exon 11

p.P278L

Homoallelic

NI

2

[8, 169]

c.917 + 4A > G

Splicing

Intron 11

–

Heteroallelic

NI

1

[197]

c.917 + 5G > A

Splicing

Intron 11

–

Homoallelic

NI

1

[169]

c.958A > G

Missense

Exon 12

p.N320D

Homoallelic

< 15%

1

[196]

c.959A > G

Missense

Exon 12

p.N320S

Homoallelic

NI

1

[131]

c.991G > A

Missense

Exon 12

p.D331N

Heteroallelic

NI

1

[169, 196]

c.997C > T

Missense

Exon 12

p.P333C

Homoallelic & Heteroallelic

NI

3

[49, 92]

c.997C > G

Missense

Exon 12

p.P333G

Heteroallelic

NI

4

[49, 131]

c.998G > A

Missense

Exon 12

p.P333H

Homoallelic

NI

1

[131]

c.1085C > G

Missense

Exon 13

p.P362R

Homoallelic

< 5%

2

[41]

c.1084C > A

Missense

Exon 13

p.P362T

Heteroallelic

NI

1

[131]

c.1096A > C

Missense

Exon 13

p.K366Q

Heteroallelic

NI

2

[49, 53]

c.1105G > A

Missense

Exon 13

p.V369I

Heteroallelic

NI

1

[199]

c.1098 + 1G > T

Splicing

Intron 13

p.N348_K366del

Heteroallelic

NI

1

[196]

c.1175A > G

Missense

Exon 14

p.R254G

Heteroallelic

NI

1

[169]

c.1186_1187insT

Insertion

Exon 14

p.*396L

NI

NI

1

[195]

  1. List of ASAH1 mutations reported in the literature that result in FD. Only pathogenic mutations are included. The number of cases column indicates any case in which one allele carries a mutation. Patients with compound mutations that are pathogenic are listed twice. The listed residual enzyme activity is expressed as a percent of the normal control; NI not indicated